Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Revenue

In the year 2025, Zevra Therapeutics had annual revenue of $106.47M with 350.91% growth. Zevra Therapeutics had revenue of $34.13M in the quarter ending December 31, 2025, with 183.36% growth.

• Revenue (ttm): $106.47M
• Revenue Growth: +350.91%
• P/S Ratio: 5.29
• Revenue / Employee: $1,745,410
• Employees: 61
• Market Cap: 556.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	106.47M	82.86M	350.91%
Dec 31, 2024	23.61M	-3.85M	-14.02%
Dec 31, 2023	27.46M	17.00M	162.58%
Dec 31, 2022	10.46M	-18.19M	-63.50%
Dec 31, 2021	28.65M	15.36M	115.61%
Dec 31, 2020	13.29M	449.00K	3.50%
Dec 31, 2019	12.84M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-